Gracell Biotechnologies (GRCL) Revenue
Market Cap: $989.87M
Avg Volume: 1.46M
Industry: Biotechnology
Sector: Healthcare
What is Gracell Biotechnologies's Revenue?
Gracell Biotechnologies's quarterly revenue as of Q3 2023 is $-.
Gracell Biotechnologies's annual revenue for the fiscal year 2022 is $-.
Related metrics for Gracell Biotechnologies (quarterly):
- Cost of Revenue: $-
- Gross Profit: $-
- Gross Profit Ratio: 0.00%
- Revenue Per Share: $-
- Revenue Growth: 0.00%
Apple's quarterly revenue was $-, with a cost of revenue of $-, which leaves $- gross profit and a gross profit ratio of 0.00%.
Related metrics for Gracell Biotechnologies (annual):
- Cost of Revenue: $-
- Gross Profit: $-
- Gross Profit Ratio: 0.00%
- Revenue Per Share: $-
- Revenue Growth: -100.00%
Apple's annual revenue was $-, with a cost of revenue of $-, which leaves $- gross profit and a gross profit ratio of 0.00%.
Understanding Revenue
Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations. It is often referred to as the "top line" because it sits at the top of the income statement.
End of Year Revenue
The table below shows the revenue for each fiscal year, with the latest data available for 2022.
| Year | Revenue | Change |
|---|---|---|
| 2022 | $- | -100.00% |
| 2021 | $366.00K | N/A |
| 2020 | $- | N/A |
| 2019 | $- | N/A |
| 2018 | $- | N/A |
Related Metrics
Explore detailed financial metrics and analysis for GRCL.